{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T10:30:17Z","timestamp":1784716217578,"version":"3.55.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-96037-z","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T17:11:12Z","timestamp":1744218672000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Trend analysis of antidepressant consumption in Italy from 2008 to 2022 in a public health perspective"],"prefix":"10.1038","volume":"15","author":[{"given":"Maitane","family":"Oscoz-Irurozqui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Villani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Ricciardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosaria","family":"Gualano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"key":"96037_CR1","doi-asserted-by":"publisher","unstructured":"Sheehan, D. V., Nakagome, K., Asami, Y., Pappadopulos, E. A. & Boucher, M. Restoring function in major depressive disorder: a systematic review. J. Affect. Disord. 215, 299\u2013313. https:\/\/doi.org\/10.1016\/j.jad.2017.02.029   (2017).","DOI":"10.1016\/j.jad.2017.02.029"},{"key":"96037_CR2","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1370\/afm.1260","volume":"9","author":"A Beck","year":"2011","unstructured":"Beck, A. et al. Severity of depression and magnitude of productivity loss. Ann. Fam Med. 9, 305\u2013311 (2011).","journal-title":"Ann. Fam Med."},{"key":"96037_CR3","unstructured":"Institute for Health Metrics and Evaluation. GBD Compare. https:\/\/vizhub.healthdata.org\/gbd-compare\/  (2021)."},{"key":"96037_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","volume":"9","author":"GBD 2019 Mental Disorders Collaborators","year":"2022","unstructured":"GBD 2019 Mental Disorders Collaborators. Global, regional, and National burden of 12 mental disorders in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet Psychiatry. 9, 137\u2013150 (2022).","journal-title":"Lancet Psychiatry"},{"key":"96037_CR5","doi-asserted-by":"crossref","unstructured":"Liu, J., Liu, Y., Ma, W., Tong, Y. & Zheng, J. Temporal and Spatial trend analysis of all-cause depression burden based on global burden of disease (GBD) 2019 study. Sci. Rep. 14, 458 (2024).","DOI":"10.1038\/s41598-024-62381-9"},{"key":"96037_CR6","unstructured":"World Health Organization (WHO). Depressive disorder (depression). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/depression (2024)."},{"key":"96037_CR7","unstructured":"World Health Organization (WHO). Global Burden of Mental Disorders and the Need for a Comprehensive, Coordinated Response from Health and Social Sectors at the Country Level  (2011)."},{"key":"96037_CR8","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/S0140-6736(21)02143-7","volume":"398","author":"DF Santomauro","year":"2021","unstructured":"Santomauro, D. F. et al. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet 398, 1700\u20131712 (2021).","journal-title":"Lancet"},{"key":"96037_CR9","unstructured":"Organization for Economic Co-operation and Development (OECD). Tackling the Mental Health Impact of the COVID-19 Crisis: an Integrated, Whole-of-Society Response  (2021)."},{"key":"96037_CR10","doi-asserted-by":"publisher","unstructured":"Gualano, M. R., Lo Moro, G., Voglino, G., Bert, F. & Siliquini, R. Monitoring the impact of COVID-19 pandemic on mental health: a public health challenge? Reflection on Italian data. Soc. Psychiatry Psychiatr. Epidemiol. 56, 165\u2013167. https:\/\/doi.org\/10.1007\/s00127-020-01971-0   (2021).","DOI":"10.1007\/s00127-020-01971-0"},{"key":"96037_CR11","unstructured":"National Health Service - United Kingdom National Health Service. Overview\u2014Antidepressants. https:\/\/www.nhs.uk\/mental-health\/talking-therapies-medicine-treatments\/medicines-and-psychiatry\/antidepressants\/overview\/ (2024)."},{"key":"96037_CR12","doi-asserted-by":"crossref","unstructured":"Alemi, F. et al. Effectiveness of common antidepressants: a post market release study. EClinicalMedicine 41, 14 (2021).","DOI":"10.1016\/j.eclinm.2021.101171"},{"key":"96037_CR13","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s00228-012-1422-3","volume":"69","author":"G Damiani","year":"2013","unstructured":"Damiani, G. et al. Impact of regional copayment policy on selective serotonin reuptake inhibitor (SSRI) consumption and expenditure in Italy. Eur. J. Clin. Pharmacol. 69, 957\u2013963 (2013).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"96037_CR14","unstructured":"Olfson, M. & Marcus, S. C. National Patterns in Antidepressant Medication Treatment (2024)."},{"key":"96037_CR15","doi-asserted-by":"crossref","unstructured":"Exeter, D., Robinson, E. & Wheeler, A. Antidepressant dispensing trends in new Zealand between 2004 and 2007. Aust. N. Z. J. Psychiatry 43, 896 (2009).","DOI":"10.3109\/00048670903279879"},{"key":"96037_CR16","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/pds.1944","volume":"19","author":"LH Mart\u00edn Arias","year":"2010","unstructured":"Mart\u00edn Arias, L. H. et al. Trends in the consumption of antidepressants in Castilla y Le\u00f3n (Spain). Association between suicide rates and antidepressant drug consumption. Pharmacoepidemiol. Drug Saf. 19, 895\u2013900 (2010).","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"96037_CR17","doi-asserted-by":"publisher","unstructured":"Verdoux, H., Tournier, M. & B\u00e9gaud, B. Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies. Acta Psychiatr. Scand.   121, 4\u201310. https:\/\/doi.org\/10.1111\/j.1600-0447.2009.01425.x    (2010).","DOI":"10.1111\/j.1600-0447.2009.01425.x"},{"key":"96037_CR18","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1176\/appi.ps.201300510","volume":"65","author":"MR Gualano","year":"2014","unstructured":"Gualano, M. R. et al. Consumption of antidepressants in Italy: recent trends and their significance for public health. Psychiatric Serv. 65, 1226\u20131231 (2014).","journal-title":"Psychiatric Serv."},{"key":"96037_CR19","doi-asserted-by":"publisher","unstructured":"OECD. Health at a Glance 2023: OECD Indicators, OECD Publishing, Paris. https:\/\/doi.org\/10.1787\/7a7afb35-en (2023).","DOI":"10.1787\/7a7afb35-en"},{"key":"96037_CR20","unstructured":"Istituto Superiore di Sanit\u00e0. Depressione in Italia anni 2021\u20132022.  https:\/\/www.epicentro.iss.it\/passi\/dati\/depressione#:~:text=Dai%20dati%20PASSI%202021%2D2022,le%20persone%20senza%20sintomi%20depressivi (2023)."},{"key":"96037_CR21","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jad.2022.11.068","volume":"323","author":"M Tiger","year":"2023","unstructured":"Tiger, M. et al. Utilization of antidepressants, anxiolytics, and hypnotics during the COVID-19 pandemic in Scandinavia. J. Affect. Disord. 323, 292\u2013298 (2023).","journal-title":"J. Affect. Disord"},{"key":"96037_CR22","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00127-023-02574-1","volume":"59","author":"T Vuki\u0107evi\u0107","year":"2024","unstructured":"Vuki\u0107evi\u0107, T., Dragani\u0107, P., \u0160kribulja, M., Puljak, L. & Do\u0161enovi\u0107, S. Consumption of psychotropic drugs in Croatia before and during the COVID-19 pandemic: a 10-year longitudinal study (2012\u20132021). Soc. Psychiatry Psychiatr Epidemiol. 59, 799\u2013811 (2024).","journal-title":"Soc. Psychiatry Psychiatr Epidemiol."},{"key":"96037_CR23","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1136\/jech-2021-216732","volume":"76","author":"M Estrela","year":"2022","unstructured":"Estrela, M. et al. Prescription of anxiolytics, sedatives, hypnotics and antidepressants in outpatient, universal care during the COVID-19 pandemic in Portugal: a nationwide, interrupted time-series approach. J. Epidemiol. Community Health (1978). 76, 335\u2013340 (2022).","journal-title":"J. Epidemiol. Community Health (1978)"},{"key":"96037_CR24","doi-asserted-by":"crossref","unstructured":"De Bandt, D., Haile, S. R., Devillers, L., Bourrion, B. & Menges, D. Prescriptions of antidepressants and anxiolytics in France 2012\u20132022 and changes with the COVID-19 pandemic: interrupted time series analysis. BMJ Mental Health 27, 71 (2024).","DOI":"10.1136\/bmjment-2024-301026"},{"key":"96037_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3399\/BJGPO.2021.0020","volume":"5","author":"P Bogowicz","year":"2021","unstructured":"Bogowicz, P. et al. Trends and variation in antidepressant prescribing in english primary care: a retrospective longitudinal study. BJGP Open. 5, 1\u201312 (2021).","journal-title":"BJGP Open."},{"key":"96037_CR26","doi-asserted-by":"crossref","unstructured":"Gusm\u00e3o, R. et al. Antidepressant utilization and suicide in Europe: an ecological Multi-National study. PLoS One 8,b145 (2013).","DOI":"10.1371\/journal.pone.0066455"},{"key":"96037_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s11126-025-10122-0","author":"A Peano","year":"2025","unstructured":"Peano, A. et al. International trends in antidepressant consumption: a 10-year comparative analysis (2010\u20132020). Psychiatr. Q. https:\/\/doi.org\/10.1007\/s11126-025-10122-0 (2025).","journal-title":"Psychiatr. Q."},{"key":"96037_CR28","doi-asserted-by":"publisher","unstructured":"Mcintyre, R. S. et al. Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions. World Psychiatry 2023, 394\u2013412. https:\/\/doi.org\/10.1002\/wps.21120 (2023).","DOI":"10.1002\/wps.21120"},{"key":"96037_CR29","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.2147\/NDT.S136343","volume":"13","author":"D Saragoussi","year":"2017","unstructured":"Saragoussi, D. et al. Factors associated with failure to achieve remission and with relapse after remission in patients with major depressive disorder in the PERFORM study. Neuropsychiatr. Dis. Treat. 13, 2151\u20132165 (2017).","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"96037_CR30","unstructured":"Karasu, B., \u00dcniversitesi, Y., Wang, P., Altshuler, K. Z. & Tasman, A. Practice guideline for the treatment of patients with major depressive disorder (Revision). http:\/\/www.appi.org\/CustomerService\/Pages\/Permissions.aspx (2000)."},{"key":"96037_CR31","unstructured":"Pratt, L. A., Brody, D. J. & Gu, Q. Antidepressant Use in Persons Aged 12 and Over: United States, 2005\u20132008 Key Findings Data from the National Health and Nutrition Examination Surveys. NCHS Data Brief   (2005)."},{"key":"96037_CR32","unstructured":"Pratt, L. A., Brody, D. J. & Gu, Q. Antidepressant Use Among Persons Aged 12 and Over: United States, 2011\u20132014 Key Findings Data from the National Health and Nutrition Examination Survey. https:\/\/www.cdc.gov\/nchs\/data\/databriefs\/db283_table.pdf#2   (2011)."},{"key":"96037_CR33","doi-asserted-by":"crossref","unstructured":"Brisnik, V. et al. Deprescribing of antidepressants: development of indicators of high-risk and overprescribing using the RAND\/UCLA appropriateness method. BMC Med. 22, (2024).","DOI":"10.1186\/s12916-024-03397-w"},{"key":"96037_CR34","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00228-012-1319-1","volume":"69","author":"G Trifir\u00f2","year":"2013","unstructured":"Trifir\u00f2, G. et al. A nationwide prospective study on prescribing pattern of antidepressant drugs in Italian primary care. Eur. J. Clin. Pharmacol. 69, 227\u2013236 (2013).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"96037_CR35","doi-asserted-by":"publisher","unstructured":"Connolly, K. R. & Thase, M. E. Emerging drugs for major depressive disorder. Expert Opin. Emerg. Drugs   17, 105\u2013126.  https:\/\/doi.org\/10.1517\/14728214.2012.660146   (2012).","DOI":"10.1517\/14728214.2012.660146"},{"key":"96037_CR36","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1192\/bjp.bp.111.104257","volume":"200","author":"S Ilyas","year":"2012","unstructured":"Ilyas, S. & Moncrieff, J. Trends in prescriptions and costs of drugs for mental disorders in England, 1998\u20132010. Br. J. Psychiatry  200, 393\u2013398 (2012).","journal-title":"Br. J. Psychiatry"},{"key":"96037_CR37","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s40273-021-01021-w","volume":"39","author":"A Arnaud","year":"2021","unstructured":"Arnaud, A., Suthoff, E., Tavares, R. M., Zhang, X. & Ravindranath, A. J. The increasing economic burden with additional steps of pharmacotherapy in major depressive disorder. Pharmacoeconomics 39, 691\u2013706 (2021).","journal-title":"Pharmacoeconomics"},{"key":"96037_CR38","doi-asserted-by":"publisher","first-page":"693","DOI":"10.2174\/1570159X19666210517150418","volume":"20","author":"TB Jannini","year":"2021","unstructured":"Jannini, T. B. et al. Off-label uses of selective serotonin reuptake inhibitors (SSRIs). Curr. Neuropharmacol. 20, 693\u2013712 (2021).","journal-title":"Curr. Neuropharmacol."},{"key":"96037_CR39","unstructured":"Ministero della Salute. Piano Di Azioni Nazionale Per La Salute Mentale (2013)."},{"key":"96037_CR40","unstructured":"Agenzia Italiana del Farmaco (AIFA). Rapporti OsMed.  https:\/\/www.aifa.gov.it\/rapporti-osmed (2024)."},{"key":"96037_CR41","doi-asserted-by":"publisher","unstructured":"Bishop, M. M., Fixen, D. R., Linnebur, S. A. & Pearson, S. M. Cognitive effects of vortioxetine in older adults: a systematic review. Therapeut. Adv. Psychopharmacol. 2021, 11. https:\/\/doi.org\/10.1177\/20451253211026796   (2021).","DOI":"10.1177\/20451253211026796"},{"key":"96037_CR42","doi-asserted-by":"publisher","unstructured":"Kok, R. M. & Reynolds, C. F. Management of depression in older adults: a review. JAMA J. Am. Med. Assoc. 317, 2114\u20132122. https:\/\/doi.org\/10.1001\/jama.2017.5706   (2017).","DOI":"10.1001\/jama.2017.5706"},{"key":"96037_CR43","unstructured":"World Health Organization (WHO). The Impact of COVID-19 on Mental, Neurological and Substance Use Services: Results of a Rapid Assessment  (2020)."},{"key":"96037_CR44","doi-asserted-by":"publisher","unstructured":"Organization for Economic Co-operation and Development (OECD). Delivering for youth: how governments can put young people at the centre of the recovery.  https:\/\/doi.org\/10.1787\/92c9d060-en (2022).","DOI":"10.1787\/92c9d060-en"},{"key":"96037_CR45","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1001\/jamapsychiatry.2023.2983","volume":"80","author":"O K\u00f6hler-Forsberg","year":"2023","unstructured":"K\u00f6hler-Forsberg, O. et al. Efficacy and safety of antidepressants in patients with comorbid depression and medical diseases: an umbrella systematic review and Meta-Analysis. JAMA Psychiatry 80, 1196\u20131207 (2023).","journal-title":"JAMA Psychiatry"},{"key":"96037_CR46","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","volume":"391","author":"A Cipriani","year":"2018","unstructured":"Cipriani, A. et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet 391, 1357\u20131366 (2018).","journal-title":"Lancet"},{"key":"96037_CR47","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1001\/archgenpsychiatry.2011.2044","volume":"69","author":"RD Gibbons","year":"2012","unstructured":"Gibbons, R. D., Hur, K., Brown, C. H., Davis, J. M. & Mann, J. J. Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of Fluoxetine and Venlafaxine. Arch. Gen. Psychiatry. 69, 572\u2013579 (2012).","journal-title":"Arch. Gen. Psychiatry"},{"key":"96037_CR48","doi-asserted-by":"publisher","unstructured":"Thornicroft, G. et al. The Lancet Commission on ending stigma and discrimination in mental health. The Lancet 400, 1438\u20131480. https:\/\/doi.org\/10.1016\/S0140-6736(22)01470-2   (2022).","DOI":"10.1016\/S0140-6736(22)01470-2"},{"key":"96037_CR49","doi-asserted-by":"publisher","unstructured":"Rabeea, S. A. et al. Surging trends in prescriptions and costs of antidepressants in England amid COVID-19. https:\/\/doi.org\/10.1007\/s40199-021-00390-z\/Published (2021).","DOI":"10.1007\/s40199-021-00390-z\/Published"},{"key":"96037_CR50","doi-asserted-by":"publisher","DOI":"10.1787\/4ed890f6-en","author":"Organization for Economic Co-operation and Development (OECD)","year":"2021","unstructured":"Organization for Economic Co-operation and Development (OECD). A new benchmark for mental health systems. OECD. https:\/\/doi.org\/10.1787\/4ed890f6-en (2021).","journal-title":"OECD"},{"key":"96037_CR51","doi-asserted-by":"publisher","DOI":"10.2806\/06591","author":"E S\u00e1ndor","year":"2021","unstructured":"S\u00e1ndor, E. et al. Impact of COVID-19 on young people in the EU. Www Eurofound Europa Eu. https:\/\/doi.org\/10.2806\/06591 (2021).","journal-title":"Www Eurofound Europa Eu"},{"key":"96037_CR52","doi-asserted-by":"crossref","unstructured":"Johnson, C. F., Williams, B., Macgillivray, S. A., Dougall, N. J. & Maxwell, M. \u2018Doing the right thing\u2019: factors influencing GP prescribing of antidepressants and prescribed doses. BMC Fam. Pract. 18, 1456 (2017).","DOI":"10.1186\/s12875-017-0643-z"},{"key":"96037_CR53","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00127-013-0717-8","volume":"49","author":"H Verdoux","year":"2014","unstructured":"Verdoux, H., Cortaredona, S., Dumesnil, H., Sebbah, R. & Verger, P. Psychotherapy for depression in primary care: a panel survey of general practitioners\u2019 opinion and prescribing practice. Soc. Psychiatry Psychiatr Epidemiol. 49, 59\u201368 (2014).","journal-title":"Soc. Psychiatry Psychiatr Epidemiol."},{"key":"96037_CR54","unstructured":"Osservatorio Nazionale sulla Salute nelle Regioni Italiane. Rapporto Osservasalute. https:\/\/osservatoriosullasalute.it\/rapporto-osservasalute (2024)."},{"key":"96037_CR55","unstructured":"World Health Organization (WHO). Defined Daily Dose (DDD). https:\/\/www.who.int\/tools\/atc-ddd-toolkit\/about-ddd (2024)."},{"key":"96037_CR56","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1080\/02664763.2022.2063265","volume":"50","author":"HJ Kim","year":"2023","unstructured":"Kim, H. J. et al. Data-driven choice of a model selection method in joinpoint regression. J. Appl. Stat. 50, 1992\u20132013 (2023).","journal-title":"J. Appl. Stat."},{"key":"96037_CR57","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.3390\/vaccines11061103","volume":"11","author":"I Aguinaga-Ontoso","year":"2023","unstructured":"Aguinaga-Ontoso, I. et al. COVID-19 impact on DTP vaccination trends in Africa: a joinpoint regression analysis. Vaccines (Basel) 11, 1103 (2023).","journal-title":"Vaccines (Basel)"},{"key":"96037_CR58","doi-asserted-by":"publisher","first-page":"e02515","DOI":"10.1016\/j.heliyon.2019.e02515","volume":"5","author":"D Gillis","year":"2019","unstructured":"Gillis, D. & Edwards, B. P. M. The utility of joinpoint regression for estimating population parameters given changes in population structure. Heliyon 5, e02515 (2019).","journal-title":"Heliyon"},{"key":"96037_CR59","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2149\/tmh.2014-12","volume":"42","author":"NP Long","year":"2014","unstructured":"Long, N. P. et al. Scientific productivity on research in ethical issues over the past half century: a joinpoint regression analysis. Trop. Med. Health 42, 121\u2013126 (2014).","journal-title":"Trop. Med. Health"},{"key":"96037_CR60","unstructured":"National Cancer Institute. Joinpoint trend analysis software. https:\/\/surveillance.cancer.gov\/joinpoint\/ (2024)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96037-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96037-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96037-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T02:01:52Z","timestamp":1744596112000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96037-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["96037"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-96037-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"5 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12124"}}